AdaptHealth director Kenneth Samet files Form 3

AdaptHealth Corp. director Kenneth A. Samet filed a Form 3, which is an initial statement of beneficial ownership for insiders.

Rhea-AI Filing Summary

AdaptHealth Corp. director Kenneth A. Samet filed a Form 3, which is an initial statement of beneficial ownership for insiders. The filing lists him as a director of the company and does not report any stock transactions or derivative positions at this time.

Key Terms

Form 3, reportingPersons, is_director

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": [ { "name": "SAMET KENNETH A" } ]"

is_director regulatory

""is_director": 1"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Kenneth A. Samet’s Form 3 filing for AHCO show?

The Form 3 filing shows that Kenneth A. Samet is a director of AdaptHealth Corp. (AHCO). It serves as his initial statement of beneficial ownership and reports no stock or derivative transactions in this submission.

Does the AHCO Form 3 for Kenneth A. Samet report any stock trades?

No, the Form 3 for Kenneth A. Samet reports no stock trades. The transaction summary lists zero buy, sell, acquire, dispose, or derivative transactions, indicating only status as a reporting director is disclosed.

Is Kenneth A. Samet a 10% owner of AdaptHealth Corp. (AHCO)?

According to the Form 3, Kenneth A. Samet is not a 10% owner of AdaptHealth Corp.. The filing marks the 10% owner field as zero while confirming his role as a director.

What insider role does Kenneth A. Samet hold at AdaptHealth Corp.?

The Form 3 identifies Kenneth A. Samet as a director of AdaptHealth Corp.. It shows he is not listed as an officer and does not hold a 10% ownership position in this filing.

Are there any derivative securities reported in Kenneth A. Samet’s AHCO Form 3?

No derivative securities are reported for Kenneth A. Samet in this Form 3. The derivative summary is empty, and the transaction summary shows zero derivative transactions or remaining derivative positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SAMET KENNETH A

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/18/2026

3. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Richard Rew as attorney in fact for Kenneth A. Samet	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)